Evaluation of Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate Treated with Energy of Consciousness (The Trivedi Effect®)
Journal of Drug Design and Medicinal Chemistry
Volume 3, Issue 1, February 2017, Pages: 5-17
Received: Jan. 31, 2017; Accepted: Feb. 22, 2017; Published: Mar. 14, 2017
Views 1904      Downloads 80
Authors
Mahendra Kumar Trivedi, Trivedi Global, Inc., Henderson, Nevada, USA
Alice Branton, Trivedi Global, Inc., Henderson, Nevada, USA
Dahryn Trivedi, Trivedi Global, Inc., Henderson, Nevada, USA
Gopal Nayak, Trivedi Global, Inc., Henderson, Nevada, USA
Alan Joseph Balmer, Trivedi Global, Inc., Henderson, Nevada, USA
Dimitrius Anagnos, Trivedi Global, Inc., Henderson, Nevada, USA
Janice Patricia Kinney, Trivedi Global, Inc., Henderson, Nevada, USA
Joni Marie Holling, Trivedi Global, Inc., Henderson, Nevada, USA
Joy Angevin Balmer, Trivedi Global, Inc., Henderson, Nevada, USA
Lauree Ann Duprey-Reed, Trivedi Global, Inc., Henderson, Nevada, USA
Vaibhav Rajan Parulkar, Trivedi Global, Inc., Henderson, Nevada, USA
Parthasarathi Panda, Trivedi Science Research Laboratory Pvt. Ltd., Bhopal, Madhya Pradesh, India
Kalyan Kumar Sethi, Trivedi Science Research Laboratory Pvt. Ltd., Bhopal, Madhya Pradesh, India
Snehasis Jana, Trivedi Science Research Laboratory Pvt. Ltd., Bhopal, Madhya Pradesh, India
Article Tools
Follow on us
Abstract
Magnesium gluconate is a classical organometallic salt used for the prevention and treatment of magnesium deficiency diseases. The objective of the current research was to explore the influence of The Trivedi Effect® - Energy of Consciousness Healing Treatment (Biofield Energy Healing Treatment) on magnesium gluconate for the change in the physicochemical, structural, thermal and behavioral properties using PXRD, PSD, FT-IR, UV-vis spectroscopy, TGA, and DSC analysis. Magnesium gluconate was divided into two parts – one part was control, while another part was treated with The Trivedi Effect® - Energy of Consciousness Healing Treatment remotely by seven renowned Biofield Energy Healers and defined as the Biofield Energy Treated sample. The PXRD analysis exhibited significant alteration of the crystal morphology of the treated sample compared with the control sample. The crystallite size of the treated sample was remarkably changed from range -69.99% to 71.40% compared with the control sample. The average crystallite size was significantly decreased in the treated sample by 13.61% compared with the control sample. Particle size analysis revealed that the particle size in the treated sample at d10, d50, and d90 value was significantly decreased by 5.19%, 26.77%, and 18.22%, respectively compared with the control sample. The treated sample’s surface area was significantly enhanced (12.82%) compared with the control sample. The FT-IR and UV-vis analysis showed that the structure of the magnesium gluconate remained the same in both the treated and control samples. The TGA analysis revealed the four steps thermal degradation of the both samples and the total weight loss of the Biofield Energy Treated sample was increased by 0.55% compared with the control sample. The DSC analysis revealed that the melting temperature of the treated sample (171.72°C) was increased by 0.21% compared with the control sample (171.36°C). The latent heat of fusion was increased by 4.66% in the treated sample compared with the control sample. This result indicated that the thermal stability of treated sample was improved compared with the control sample. The current study infers that The Trivedi Effect® - Biofield Energy Healing might lead to a new polymorphic form of magnesium gluconate, which would be more soluble, bioavailable, and thermally stable compared with the untreated compound. Hence, the treated magnesium gluconate would be very useful to design better nutraceutical/pharmaceutical formulations that might offer better therapeutic responses against inflammatory diseases, immunological disorders, stress, aging and other chronic infections.
Keywords
Magnesium gluconate, Consciousness Energy Healing Treatment, Biofield Energy Healing Treatment, Biofield Energy Healers, The Trivedi Effect®, PXRD, Particle size, Surface area, TGA, DSC
To cite this article
Mahendra Kumar Trivedi, Alice Branton, Dahryn Trivedi, Gopal Nayak, Alan Joseph Balmer, Dimitrius Anagnos, Janice Patricia Kinney, Joni Marie Holling, Joy Angevin Balmer, Lauree Ann Duprey-Reed, Vaibhav Rajan Parulkar, Parthasarathi Panda, Kalyan Kumar Sethi, Snehasis Jana, Evaluation of Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate Treated with Energy of Consciousness (The Trivedi Effect®), Journal of Drug Design and Medicinal Chemistry. Vol. 3, No. 1, 2017, pp. 5-17. doi: 10.11648/j.jddmc.20170301.12
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Swaminathan R (2003) Magnesium metabolism and its disorders. Clin Biochem Rev 24: 47-66.
[2]
Grubbs RD, Maguire ME (1987) Magnesium as a regulatory cation: Criteria and evaluation. Magnesium 6: 113-127.
[3]
Guerrera MP, Volpe SL, Mao JJ (2009) Therapeutic uses of magnesium. Am Fam Physician 80: 157-162.
[4]
Gums JG (2004) Magnesium in cardiovascular and other disorders. Am J Health Syst Pharm 61: 1569-1576.
[5]
Gröber U, Schmidt J, Kisters K (2015) Magnesium in prevention and therapy. Nutrients 7: 8199-8226.
[6]
Sales CH, Pedrosa Lde F (2006) Magnesium and diabetes mellitus: Their relation. Clin Nutr 25: 554-562.
[7]
Nageris BI, Ulanovski D, Attias J (2004) Magnesium treatment for sudden hearing loss. Ann Otol Rhinol Laryngol 113: 672-675.
[8]
Lysakowski C, Dumont L, Czarnetzki C, Tramer MR (2007) Magnesium as an adjuvant to postoperative analgesia: A systematic review of randomized trials. Anesth Analg 104: 1532-1539.
[9]
Murphy JD, Paskaradevan J, Eisler LL, Ouanes JP, Tomas VA, Freck EA, Wu CL (2013) Analgesic efficacy of continuous intravenous magnesium infusion as an adjuvant to morphine for postoperative analgesia: A systematic review and meta-analysis. Middle East J Anaesthesiol 22: 11-20.
[10]
Ramachandran S, Fontanille P, Pandey A, Larroche C (2006) Gluconic acid: Properties, applications and microbial production. Food Technol Biotechnol 44: 185-195.
[11]
Fleming TE, Mansmann Jr HC (1999) Methods and compositions for the prevention and treatment of diabetes mellitus. United States Patent 5871769, 1-10.
[12]
Fleming TE, Mansmann Jr HC (1999) Methods and compositions for the prevention and treatment of immunological disorders, inflammatory diseases and infections. United States Patent 5939394, 1-11.
[13]
Weglicki WB (2000) Intravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distribution. United States Patent 6100297, 1-6.
[14]
Lee KH, Chung SH, Song JH, Yoon JS, Lee J, Jung MJ, Kim JH (2013) Cosmetic compositions for skin-tightening and method of skin-tightening using the same. United States Patent 8580741 B2.
[15]
Martin RW, Martin JN Jr, Pryor JA, Gaddy DK, Wiser WL, Morrison JC (1988) Comparison of oral ritodrine and magnesium gluconate for ambulatory tocolysis. Am J Obstet Gynecol 158: 1440-1445.
[16]
Jahnen-Dechent W, Ketteler M (2012) Magnesium basics. Clin Kidney J 5: i3-i14.
[17]
Fine KD, Santa Ana CA, Porter JL, Fordtran JS (1991) Intestinal absorption of magnesium from food and supplements. J Clin Invest 88: 396-402.
[18]
Coudray C, Rambeau M, Feillet-Coudray C, Gueux E, Tressol JC, Mazur A, Rayssiguier Y (2005) Study of magnesium bioavailability from ten organic and inorganic Mg salts in Mg-depleted rats using a stable isotope approach. Magnes Res 18: 215-223.
[19]
Stenger VJ (1999) Bioenergetic Fields. The Scientific Review of Alternative Medicine 3.
[20]
Rogers, M (1989) "Nursing: A Science of Unitary Human Beings." In J. P. Riehl-Sisca (ed.) Conceptual Models for Nursing Practice. 3rd edition. Norwark: Appleton & Lange.
[21]
Hammerschlag R, Jain S, Baldwin AL, Gronowicz G, Lutgendorf SK, Oschman JL, Yount GL (2012) Biofield research: A roundtable discussion of scientific and methodological issues. J Altern Complement Med 18: 1081-1086.
[22]
Koithan M (2009) Introducing complementary and alternative therapies. J Nurse Pract 5: 18-20.
[23]
Trivedi MK, Branton A, Trivedi D, Nayak G, Singh R, Jana S (2015) Physical, thermal and spectroscopic characterization of biofield treated p-chloro-m-cresol. J Chem Eng Process Technol 6: 249.
[24]
Trivedi MK, Patil S, Shettigar H, Singh R, Jana S (2015) An impact of biofield treatment on spectroscopic characterization of pharmaceutical compounds. Mod Chem Appl 3: 159.
[25]
Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak G, Latiyal O, Mishra RK, Jana S (2015) Physicochemical characterization of biofield energy treated calcium carbonate powder. American Journal of Health Research 3: 368-375.
[26]
Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak G, Mishra RK, Jana S (2015) Biofield treatment: A potential strategy for modification of physical and thermal properties of gluten hydrolysate and ipomoea macroelements. J Nutr Food Sci 5: 414.
[27]
Trivedi MK, Branton A, Trivedi D, Nayak G, Bairwa K, Jana S (2015) Evaluation of physical, thermal and spectral parameters of biofield energy treated methylsulfonylmethane. J Mol Pharm Org Process Res 3: 129.
[28]
Trivedi MK, Branton A, Trivedi D, Nayak G, Bairwa K, Jana S (2015) Physicochemical and spectroscopic characterization of p-chlorobenzaldehyde: an impact of biofield energy treatment. Insights in Analytical Electrochemistry 1: 5.
[29]
Trivedi MK, Branton A, Trivedi D, Nayak G, Panda P, Jana S (2016) Determination of isotopic abundance of 13C/12C or 2H/1H and 18O/16O in biofield energy treated 1-chloro-3-nitrobenzene (3-CNB) using gas chromatography-mass spectrometry. Science Journal of Analytical Chemistry. 4: 42-51.
[30]
Trivedi MK, Branton A, Trivedi D, Nayak G, Sethi KK, Jana S (2016) Gas Chromatography-Mass Spectrometry Based Isotopic Abundance Ratio Analysis of Biofield Energy Treated Methyl-2-napthylether (Nerolin). American Journal of Physical Chemistry. 5: 80-86.
[31]
Trivedi MK, Nayak G, Patil S, Tallapragada RM, Latiyal O (2015) Evaluation of biofield treatment on physical, atomic and structural characteristics of manganese (II, III) oxide. J Material Sci Eng 4: 177.
[32]
Trivedi MK, Nayak G, Tallapragada RM, Patil S, Latiyal O, Jana S (2015) Effect of biofield treatment on structural and morphological properties of silicon carbide. J Powder Metall Min 4: 132.
[33]
Trivedi MK, Tallapragada RM, Branton A, Trivedi D, Nayak G, Latiyal O, Jana S (2015) Evaluation of thermal and physical properties of magnesium nitride powder: impact of biofield energy treatment. Ind Eng Manage 4: 177.
[34]
Trivedi MK, Branton A, Trivedi D, Nayak G, Gangwar M, Jana S (2016) Molecular analysis of biofield treated eggplant and watermelon crops. Adv Crop Sci Tech 4: 208.
[35]
Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, Jana S (2015) Evaluation of biochemical marker - glutathione and DNA fingerprinting of biofield energy treated Oryza sativa. American Journal of BioScience 3: 243-248.
[36]
Trivedi MK, Branton A, Trivedi D, Nayak G, Singh R, Jana S (2015) Physicochemical characterization of biofield treated orchid maintenance/replate medium. Journal of Plant Sciences. 3: 285-293.
[37]
Trivedi MK, Branton A, Trivedi D, Nayak G, Gangwar M, Jana S (2015) Characterization of phenotype and genotype of biofield treated Enterobacter aerogenes. Transl Med 5: 155.
[38]
Trivedi MK, Branton A, Trivedi D, Nayak G, Gangwar M, Jana S (2015) Bacterial identification using 16S rDNA gene sequencing and antibiogram analysis on biofield treated Pseudomonas fluorescens. Clin Med Biochemistry Open Access 1: 101.
[39]
Trivedi MK, Patil S, Harish S, Gangwar M, Jana S (2015) Biofield Treatment: An alternative approach to combat multidrug-resistant susceptibility pattern of Raoultella ornithinolytica. Altern Integr Med 4: 193.
[40]
Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, Jana S (2015) Antibiogram, biochemical reactions and biotyping of biofield treated Providencia rettgeri. American Journal of Health Research 3: 344-351.
[41]
Ranade VV, Somberg JC (2001) Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. Am J Ther 8: 345-357.
[42]
Chereson R (2009) Bioavailability, bioequivalence, and drug selection. In: Makoid CM, Vuchetich PJ, Banakar UV (eds) Basic pharmacokinetics (1st Edn) Pharmaceutical Press, London.
[43]
Blagden N, de Matas M, Gavan PT, York P (2007) Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev 59: 617-630.
[44]
Trivedi MK, Mohan TRR (2016) Biofield energy signals, energy transmission and neutrinos. American Journal of Modern Physics 5: 172-176.
[45]
Chauhan A, Chauhan P (2014) Powder XRD technique and its applications in science and technology. J Anal Bioanal Tech 5: 212.
[46]
Alexander L, Klug HP (1950) Determination of crystallite size with the X-Ray Spectrometer. J App Phys 21: 137.
[47]
Langford JI, Wilson AJC (1978) Scherrer after sixty years: A survey and some new results in the determination of crystallite size. J Appl Cryst 11: 102-113.
[48]
Inoue M, Hirasawa I (2013) The relationship between crystal morphology and XRD peak intensity on CaSO4. 2H2O. J Crystal Growth 380: 169-175.
[49]
Raza K, Kumar P, Ratan S, Malik R, Arora S (2014) Polymorphism: The phenomenon affecting the performance of drugs. SOJ Pharm Pharm Sci 1: 10.
[50]
Brittain HG (2009) Polymorphism in pharmaceutical solids in Drugs and Pharmaceutical Sciences, volume 192, 2nd Edn, Informa Healthcare USA, Inc., New York.
[51]
Murray HH, Lyons SC (1960) Further correlation of kaolinite crystallinity with chemical and physical properties. Clays Clay Miner 8: 11-17.
[52]
Sun J, Wang F, Sui Y, She Z, Zhai W, Wang C, Deng Y (2012) Effect of particle size on solubility, dissolution rate, and oral bioavailability: Evaluation using coenzyme Q10 as naked nanocrystals. Int J Nanomed 7: 5733-5744.
[53]
Khadka P, Ro J, Kim H, Kim I, Kim JT, Kim H, Cho JM, Yun G, Lee J (2014) Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm Sci 9: 304-316.
[54]
Buckton G, Beezer AE (1992) The relationship between particle size and solubility. Int J Pharmaceutics 82: R7-R10.
[55]
Nikolic VD, Illic DP, Nikolic LB, Stanojevic LP, Cakic MD, Tacic AD, Ilic-Stojanovic SS (2014) The synthesis and characterization of iron (II) gluconate. Advanced Technologies 3: 16-24.
[56]
Ji L, Yin W, Fu-Jia M (2004) Confirmation of the chemical structure of magnesium gluconate. Pharmaceutical Care and Research 4: 272-273.
[57]
Hesse M, Meier H, Zeeh B (1997) Spectroscopic methods in organic chemistry, Georg Thieme Verlag Stuttgart, New York.
[58]
Alves R, Reis TVS, Silva LCC, Storpírtis S, Mercuri LP, Matos JR (2010) Thermal behavior and decomposition kinetics of rifampicin polymorphs under isothermal and non-isothermal conditions. Braz J Pharm Sci 46: 343-351.
ADDRESS
Science Publishing Group
548 FASHION AVENUE
NEW YORK, NY 10018
U.S.A.
Tel: (001)347-688-8931